Majority Of Cancer-Related Anemia Patients Treated With PROCRIT(R) (Epoetin Alfa) Once Every Three Weeks Achieved Target Hemoglobin

... New investigational study results report that 80,000 units of PROCRIT(R) (Epoetin alfa) administered once every three weeks may increase hemoglobin (Hb) levels and improve quality of life in patients with non-myeloid malignancies who are not receiving chemotherapy or radiation therapy. [click link for full article] ...